Picture of JFL Life Sciences logo

JFLLIFE JFL Life Sciences Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapContrarian

Annual cashflow statement for JFL Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
C2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line7.473837.23861.3
Depreciation
Non-Cash Items11.420.714.48.3410.7
Other Non-Cash Items
Changes in Working Capital-80.2-39.2-14733.3-117
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-58.723.2-90.684.1-35.3
Capital Expenditures-17.2-16.9-61.1-3.95
Purchase of Fixed Assets
Other Investing Cash Flow Items0.7919.88.60.2643.85
Sale of Fixed Assets
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities-16.4-7.18.6-60.9-0.104
Financing Cash Flow Items-12-20.8-14.3-8.6-10.8
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities72.5-14.680.7-23.535.4
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-2.611.5-1.3-0.252-0.002